Reilly Financial Advisors’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Reilly Financial Advisors’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-300	Closed	-$12K	–	963
2016 Q3	$12K	Buy	+300	New	+$3.35K	﹤0.01%	505

Reilly Financial Advisors's TBRA Position: Q4 2016 in Review

Reilly Financial Advisors sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 300 shares — an estimated $12K sold.

Reilly Financial Advisors first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $12K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Reilly Financial Advisors reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Reilly Financial Advisors sold 300 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $12K.
Reilly Financial Advisors first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Reilly Financial Advisors's Tobira Therapeutics, Inc. Common Stock position peaked at $12K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Reilly Financial Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.